Angeles Zambrano-Mecate
Von Esmarch Str. 56
Muenster, NW 48149, Germany
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier.
Journal: Antiviral research
Published: August 05, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages.
Journal: The European respiratory journal
Published: October 15, 2021
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
Journal: Cellular and molecular life sciences : CMLS
Published: September 27, 2021
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro.
Journal: Pharmaceutics
Published: July 20, 2021
Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function.
Journal: Journal of virology
Published: December 11, 2020
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
Journal: British journal of pharmacology
Published: October 19, 2020
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.
Journal: Emerging microbes & infections
Published: September 25, 2020
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly.
Journal: PLoS pathogens
Published: January 24, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026